News | April 09, 2026
OPPI and NIPER Raebareli partner to boost pharma research and talent
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
Machine learning approach to systems biology combined with ligand discovery platform
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
The regulatory decision follows promising results from RIVER-81
The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Revenue from operations climbed 13% to Rs. 886.87 crore
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
